HEALY JAMES

SEC Form 4 insider
Rapport Therapeutics, Inc. ($RAPP)
1 thesis · first seen Oct 31, 2026
WindowThesesResolvedWinsWin rateAvg returnMedian return
1d——————
3d——————
1w——————
1m——————
3m——————
6m——————
1y——————

Past performance does not predict future results. Informational only, not investment advice.

Thesis history

$RAPPSEC Form 4bullish
HEALY JAMES · Rapport Therapeutics, Inc. · 3h agono track record yet
Long 969,480 shares of RAPP
Bought 969,480 @ $21.00 avg · $20,359,080 · 2026-10-28

Form 4: HEALY JAMES bought RAPP

HEALY JAMES (Director at Rapport Therapeutics, Inc.) reported an open-market purchase of 969,480 shares of RAPP at an average $21.00, roughly $20,359,080, in a Form 4 filed 2026-10-30.

At post $25.05Now $24.21-3.4% since postedas of Oct 29, 4:01 PM ET
View filing on SEC.gov →

End of results.